LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Stem Cells Plus BMP-2 Fracture Remedy
Biologics

Stem Cells Plus BMP-2 Fracture Remedy

December 18, 2012 1 min read Premium comments

Advertisement

Stem Cells Plus BMP-2 Fracture Remedy
Source: Morquefile.com and pschubert
Secondary

A Vienna researcher developed a new treatment for severe orthopedic injuries to the extremities during her research fellowship at the Center for Advanced Orthopedic Studies at the Harvard Medical School. The researcher is Martina Hauser-Schinhan from the University Department of Orthopaedics at the MedUni, Vienna, Austria.

In her research Hauser-Schinhan used the body’s own stem cells, obtained from fat or bone marrow, combined with BMP-2 genes which, she said, are known to promote bone healing. She embedded the autologous stem cells, genetically modified with ad.BMP-2, in a fibrin gel which she applied between the two broken parts of the bone. She reported that the stem cells continuously produce BMP-2, like a power plant, with the combination causing the bones to heal. “Until now, in cases of severe injury that we would be able to treat with this method, amputations or bone shortening surgery were often necessary, ” she said.

Hauser-Schinhan said that the new treatment option has been used in in vivo trials and clinical studies are set to follow. The results so far invite the conclusion that healing occurs within a few weeks. “Its use even after the removal of bony tumors, which involves taking away large portions of bone, appears to be possible, ” she said.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy